Effects of Castration Therapy on Prostate Cancer
Author Information
Author(s): P Stattin, P Westin, J-E Damber, A Bergh
Primary Institution: Umeå University, Umeå, Sweden
Hypothesis
Can short-term effects of castration therapy predict clinical response in prostate cancer patients?
Conclusion
Castration therapy induces morphological changes and increases the apoptotic index in responding prostate tumors, which may help predict clinical outcomes.
Supporting Evidence
- 14 out of 15 responding tumors showed regressive changes after therapy.
- The median apoptotic index increased from 2.6 to 3.5 among responders.
- Median bcl-2 index increased from 1.5 to 10.0 in responders after therapy.
- Only 4 out of 13 non-responders showed regressive morphology after therapy.
Takeaway
When doctors give castration therapy to prostate cancer patients, they can look at the tumor cells to see if the treatment is working just a week later.
Methodology
Biopsies were taken from patients before and after castration therapy, and various cellular effects were assessed.
Limitations
The study had a small sample size and limited tissue from patients, which may affect the results.
Participant Demographics
Patients aged 74-85 years with advanced prostate cancer.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website